Tissue Repair Gel in Venous Leg Ulcers (US) (NCT06707090)
A Phase 3 Randomized, Parallel Group, Double-Blind Study to Evaluate the Efficacy, Tolerability, and Safety of TR987® 0.1% Gel Versus Standard of Care in the Treatment of Chronic Venous Insufficiency Leg Ulcers (VLU)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Who can join: Review the eligibility criteria below.
Location: Clincial Research Site 21 — Tucson, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (33 Sites)
Showing the first 25 of 33 sites.
- Clincial Research Site 21 — Tucson, Arizona
- Clincial Research Site 43C — Castro Valley, California
- Clincial Research Site 14 — Fresno, California
- Clincial Research Site 11 — Los Angeles, California
- Clincial Research Site 43A — San Francisco, California
- Clincial Research Site 43B — San Francisco, California
- Clincial Research Site 54 — Vista, California
- Clincial Research Site 47 — Deerfield Beach, Florida
- Clincial Research Site 38 — Hollywood, Florida
- Clincial Research Site 40 — Jacksonville, Florida
- Clincial Research Site 19 — Miami, Florida
- Clincial Research Site 26 — Miami, Florida
- Clincial Research Site 13 — Pembrook Pines, Florida
- Clincial Research Site 51 — Tamarac, Florida
- Clincial Research Site 22 — Chicago, Illinois
- Clincial Research Site 34 — Chicago, Illinois
- Clincial Research Site 10 — O'Fallon, Illinois
- Clincial Research Site 49 — Springfield, Illinois
- Clincial Research Site 04 — Bossier City, Louisiana
- Clincial Research Site 01 — Lafayette, Louisiana
- Clincial Research Site 07 — D'Iberville, Mississippi
- Clincial Research Site 02 — McComb, Mississippi
- Clincial Research Site 30 — New York, New York
- Clincial Research Site 37 — Syosset, New York
- Clincial Research Site 55 — Winston-Salem, North Carolina
📞 Contact the Study Coordinator
Phone: (+61) 280 034 554
Email: anhthu.nguyen@trtherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Leg Ulcer
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) — Hialeah, Florida
- Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers — Los Angeles, California
- LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults — Los Angeles, California
- Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. — Monroeville, Pennsylvania
- Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers — Alexandria, Louisiana
Explore by condition: All Venous Leg Ulcer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.